Atlas Trials

Novel Biomarkers Related Xuebijing Injection Improves Sepsis

Clinical trial NCT06920420 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06920420
Sponsor
Southeast University, China
Status
NOT_YET_RECRUITING
Study type
OBSERVATIONAL
Sepsis
Start date
2025-03-30
Primary completion
2028-12-31
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.